TGFB1 and neoplasm: Moreover, the NicheNetR analysis revealed the potential ligands expressed by C3–4 of LN tumor cells that drive exhausted signatures of CD8 TDYS in RR TFHL, including IL21, TNF, TGFB1, CD80, and CD86 (Fig. S14B–D).